Paul Boucher

CEO and President at Parion Sciences, Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Raleigh, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • CEO and President
      • Apr 2014 - Present

      Durham, NC Parion is a privately held, development stage pharmaceutical company focused is on treating unmet respiratory indications resulting from defects of the innate mucosal defense. Parion's pipeline includes a diverse range of novel small molecules for the treatment of Primary Ciliary Dyskinesia, Cystic Fibrosis, COPD, and Asthma. Our lead program, P-1037 Inhalation Solution, has the potential to be the first-in-class treatment for the severe, rare disease, Primary Ciliary Dyskinesia.

    • VP, Finance and Business
      • Jan 2006 - Mar 2012

      Durham, NC

    • Corporate Account Manager
      • Jan 2005 - Jan 2006

      Torrance, Ca

    • Senior Real Estate Portfolio Associate
      • Aug 2002 - Jan 2005

      Torrance, CA

    • Graduate Management Associate
      • Aug 2000 - Jul 2002

      Torrance, CA

Education

  • UNC Kenan-Flagler Business School
    1998 - 2000
  • University of North Carolina at Chapel Hill
    Master of Business Administration (M.B.A.)
    1998 - 2000
  • Rensselaer Polytechnic Institute
    BS, Civil Engineering
    1990 - 1994

Community

You need to have a working account to view this content. Click here to join now